New study links persistent SARS-CoV-2 proteins to long COVID symptoms

FHS
October 9, 2024
11:27 pm

Brigham researchers found people with wide-ranging long COVID symptoms were twice as likely to have SARS-CoV-2 proteins in their blood, compared to those without long COVID symptoms.

Biotech Stocks Well-PositionedFor The Fourth Quarter • Prudent Biotech

Biotechs are relatively better positioned in this fourth quarter compared to the broader market. The path of interest rates is clearer for 2022 and the

October 11, 2022

Beta-Blockers Tied to Delayed Huntington’s Disease Progression

Beta-blocker use was tied with slower symptom progression in people with early motor-manifest Huntington’s disease. In a people with genetically confirmed premanifest Huntington’s, beta-blocker use

December 3, 2024

First Treatment Approved for Molluscum Contagiosum

Topical cantharidin (Ycanth) was approved as the first treatment specifically for molluscum contagiosum, the FDA announced. Molluscum contagiosum is a viral skin infection that affects

July 25, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.